Outro
New York, United States
◆ Total Raised
$7M
◆ Stage
seed
◆ Location
New York, United States
◆ Team size
1-10
◆ Links
◆ About Outro
A New York-based healthcare company providing a specialized deprescribing platform to help patients safely discontinue psychiatric medications.
◆ What sets it apart
Outro combines licensed clinical care, hyperbolic tapering grounded in deprescribing science, adaptive symptom monitoring, and personalized medication management specifically for psychiatric-medication discontinuation.[3][8]
◆ Sectors
◆ Business
ModelSaaS
CustomerPatients seeking to safely taper off antidepressants and other psychiatric medications, as well as PCPs, psychiatrists, and therapists who refer them.[2][3]
◆ Notable
- Built a deprescribing platform based on hyperbolic tapering and the Maudsley Deprescribing Guidelines.[1][4]
- Launched a clinician-supervised antidepressant taper-management program with custom prescriptions, monitoring, and ongoing support.[3][6]
◆ Funding rounds
◆ Explore the market
◆ FAQ
What does Outro do?
A New York-based healthcare company providing a specialized deprescribing platform to help patients safely discontinue psychiatric medications.
Where is Outro based?
Outro is based in New York, United States.
How much has Outro raised?
Outro has raised $7M in tracked funding and is currently at the seed stage.